CDTX
Price
$12.47
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
XBIO
Price
$3.92
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Ad is loading...

CDTX vs XBIO

Header iconCDTX vs XBIO Comparison
Open Charts CDTX vs XBIOBanner chart's image
Cidara Therapeutics
Price$12.47
Change-$0.00 (-0.00%)
Volume$8.43K
CapitalizationN/A
Xenetic Biosciences
Price$3.92
Change-$0.00 (-0.00%)
Volume$4.93K
CapitalizationN/A
View a ticker or compare two or three
CDTX vs XBIO Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CDTX vs. XBIO commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a StrongBuy and XBIO is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (CDTX: $12.47 vs. XBIO: $3.92)
Brand notoriety: CDTX and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 41% vs. XBIO: 38%
Market capitalization -- CDTX: $75.59M vs. XBIO: $6.66M
CDTX [@Biotechnology] is valued at $75.59M. XBIO’s [@Biotechnology] market capitalization is $6.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDTX and XBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • CDTX’s TA Score: 4 bullish, 5 bearish.

Price Growth

CDTX (@Biotechnology) experienced а +11.14% price change this week, while XBIO (@Biotechnology) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

XBIO is expected to report earnings on Aug 11, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($75.6M) has a higher market cap than XBIO($6.66M). XBIO YTD gains are higher at: 13.620 vs. CDTX (-21.474). XBIO has higher annual earnings (EBITDA): -5.01M vs. CDTX (-30.06M). CDTX has more cash in the bank: 164M vs. XBIO (7.3M). XBIO has less debt than CDTX: XBIO (153K) vs CDTX (4.3M). CDTX has higher revenues than XBIO: CDTX (53.9M) vs XBIO (2.52M).
CDTXXBIOCDTX / XBIO
Capitalization75.6M6.66M1,135%
EBITDA-30.06M-5.01M600%
Gain YTD-21.47413.620-158%
P/E RatioN/AN/A-
Revenue53.9M2.52M2,139%
Total Cash164M7.3M2,247%
Total Debt4.3M153K2,810%
FUNDAMENTALS RATINGS
CDTX vs XBIO: Fundamental Ratings
CDTX
XBIO
OUTLOOK RATING
1..100
1480
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5259
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (14) in the Biotechnology industry is in the same range as XBIO (19). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XBIO (100). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

XBIO's SMR Rating (96) in the Biotechnology industry is in the same range as CDTX (98). This means that XBIO’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (52) in the Biotechnology industry is in the same range as XBIO (59). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XBIO (100). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-1.03%
BPTSY - CDTX
92%
Closely correlated
-2.90%
IVVD - CDTX
36%
Loosely correlated
+5.74%
CPRX - CDTX
35%
Loosely correlated
+1.91%
CABA - CDTX
33%
Poorly correlated
+4.86%
TRAW - CDTX
30%
Poorly correlated
-0.30%
More

XBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
+3.29%
SYRE - XBIO
34%
Loosely correlated
-1.18%
VXRT - XBIO
29%
Poorly correlated
+1.43%
EDSA - XBIO
29%
Poorly correlated
N/A
CDTX - XBIO
28%
Poorly correlated
-1.03%
AUTL - XBIO
27%
Poorly correlated
+2.48%
More